The patient support programme which offers patients and healthcare professionals access to nurses and specially developed materials to help patients through the first year of their GILENYA®▼ (fingolimod) journey.Show more

GIL19-C053d(1) November 2020.

Ask Speakers


Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]